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Amplification of genes in breast cancer cells was shown
to be coordinated in the majority of cases assuming the
presence of common undisclosed mechanism underlying
intrachromosomal gene amplification process.
Overexpression and amplification of the HER-2/neu
gene is observed in 20–30% of breast cancer cases and
predicts more frequent relapse and shorter survival
time. However, the initial events and molecular mechan-
isms of chromosomal aberrations in the region around
HER2/neu as well as the precise boundaries of amplified
regions remain to be obscure. This study was an
attempt to define the boundaries of amplified chromo-
some 17q12-q21 region around HER2/neu gene. Struc-
tural peculiarities of amplification boundary regions
were investigated by various techniques.
Gene dosage analysis was performed for several genes
located around HER2/neu gene in 154 breast cancer tis-
sue samples. The copy number of the ppparbp, her2/neu,
znfn1a3 Casc3 and top2a genes were analyzed by com-
parative TaqMan real time PCR. Fifty six samples (36 %)
were found to be her2/neu-amplified (NHER2/neu ≥ 1,5),
the boundaries for HER2-containing amplicons were
mapped.
Observed results suggest that similar positions of
amplified region boundaries in different breast cancer
samples are not accidental and may be related with the
DNA structural and/or sequence peculiarities of bound-
ary regions. Trying to find “special” sequences at the
amplicon boundaries, we performed the analysis of
sequence flexibility in the region TBC1D3– HER2/neu –
TOP2A using the TwistFlex program. The analysis
revealed several high flexible sequences in SOCS7,
FBX047, HER2/neu and ZNFN1A3 genes. The locations
of amplified region boundaries in 30% of cases were
inside ZNFN1A3 gene. Organization of DNA sequence
and nucleotide composition of FlexZNF-1 and
FlexZNF-2 were similar to AT-rich islands of common
fragile site (FS). Sequences of FlexZNF-1 and FlexZNF-2
have strong potential to form secondary structures
according to the analysis by Mfold software (GCG Wis-
consin PackageTM).
Thus, the analysis of DNA sequence in TBC1D3–
HER2/neu – TOP2A region revealed the existence of
two flexible sequences in the ZNFN1A3 gene sequence
with the strong potential to form stable secondary struc-
tures which may affect normal DNA replication at these
sites and result in DNA double strand break appearance.
The location of FlexZNF-1 and FlexZNF-2 strongly
coincided with the location of amplified around HER2/
neu gene fragment boundaries observed by real time
PCR analysis.
This observation indicates involvement of Flex sites in
the process of intrachromosomal DNA amplification.
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